CMG
Chipotle Mexican Grill, Inc.
CMG has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CMG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CMG's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $35.17 | — |
| Current | 33x | $35.17 | — |
| Cheap | 37x | $39.28 | +12% |
| Fair | 56x | $59.81 | +70% |
| Expensive | 91x | $97.34 | +177% |
Historical ranges are pointers, not guarantees.
CMG's PE is in its cheap range at 33x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CMG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CMG, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +19% |
| Q3 2026 | $1.07 | -5.3% |
| Q2 2026 | $1.09 | -2.7% |
| Q1 2026 | $1.09 | -3.5% |
| Q4 2025 | $1.14 | +2.7% |
| Q3 2025 | $1.13 | +5.6% |
| Q2 2025 | $1.12 | +9.8% |
| Q1 2025 | $1.13 | +20% |
| Q4 2024 | $1.11 | +25% |
CMG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +9.6% |
| Q2 2026 | $3.3B | +9.3% |
| Q1 2026 | $3.1B | +7.4% |
| Q4 2025 | $3B | +4.9% |
| Q3 2025 | $3B | +7.5% |
| Q2 2025 | $3.1B | +3% |
| Q1 2025 | $2.9B | +6.4% |
| Q4 2024 | $2.8B | +13% |
CMG's revenue has grown year over year every quarter since late 2020: $3.3B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -2.2 points |
| Q2 2026 | 16% | -2.6 points |
| Q1 2026 | 13% | -3.8 points |
| Q4 2025 | 14% | -0.5 points |
| Q3 2025 | 16% | -1.1 points |
| Q2 2025 | 18% | -1.5 points |
| Q1 2025 | 17% | +0.3 points |
| Q4 2024 | 15% | +0.2 points |
CMG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CMG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $347.1M | -15% |
| Q2 2026 | $463.4M | +16% |
| Q1 2026 | $471M | +14% |
| Q4 2025 | $228.4M | -35% |
| Q3 2025 | $406.2M | +36% |
| Q2 2025 | $400.7M | -5.1% |
| Q1 2025 | $412.3M | -5.6% |
| Q4 2024 | $353.9M | +278% |
CMG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
CMG has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 56.0 | Neutral |
CMG's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CMG PE vs Consumer Cyclical Sector
| Metric | CMG | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 18x | 82% above |
| PE % | 11 | 47 | 36 pts below |
CMG is trading at 33x earnings, a 82% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.8 | 11% above |
| 20 week MA | $33.8 | 4.1% above |
| 50 week MA | $34.6 | 1.7% above |
| 100 week MA | $41.3 | 15% below |
| 200 week MA | $44.6 | 21% below |
CMG has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $28.3 | +69% |
| 2021 | $28.3 | $35.0 | +24% |
| 2022 | $35.0 | $28.3 | -19% |
| 2023 | $28.3 | $45.7 | +62% |
| 2024 | $45.7 | $60.8 | +33% |
| 2025 | $60.8 | $37.8 | -38% |
| 2026 YTD | $37.8 | $35.2 | -7% |
CMG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.